Global Hemostatic Gel Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Hemostatic Gel Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China"s hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

According to our (Global Info Research) latest study, the global Hemostatic Gel market size was valued at US$ 1030 million in 2023 and is forecast to a readjusted size of USD 1451 million by 2030 with a CAGR of 5.1% during review period.

Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.

In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.

This report is a detailed and comprehensive analysis for global Hemostatic Gel market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Hemostatic Gel market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Hemostatic Gel market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Hemostatic Gel market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Hemostatic Gel market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Hemostatic Gel

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Hemostatic Gel market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, J&J, CryoLife, Integra Life Sciences, Advance Medical Solution, BD, CSL Behring, Pfizer, B Braun, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Hemostatic Gel market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Fibrin
Gelatin
Other

Market segment by Application
Minimally Invasive Surgery
General Surgery
Others

Major players covered
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Hemostatic Gel product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Hemostatic Gel, with price, sales quantity, revenue, and global market share of Hemostatic Gel from 2019 to 2024.

Chapter 3, the Hemostatic Gel competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hemostatic Gel breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hemostatic Gel market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Hemostatic Gel.

Chapter 14 and 15, to describe Hemostatic Gel sales channel, distributors, customers, research findings and conclusion.